Erfan, G. et al. 2016. Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors. Acta Dermato-Venereologica. 97, 2 (Sep. 2016), 258–260. DOI:https://doi.org/10.2340/00015555-2488.